MAFFICINI, Andrea
 Distribuzione geografica
Continente #
EU - Europa 7.089
NA - Nord America 6.738
AS - Asia 5.106
SA - Sud America 746
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 165
OC - Oceania 19
Totale 20.127
Nazione #
US - Stati Uniti d'America 6.522
RU - Federazione Russa 2.578
SG - Singapore 1.796
CN - Cina 1.613
GB - Regno Unito 1.544
IT - Italia 1.028
BR - Brasile 574
VN - Vietnam 452
HK - Hong Kong 430
DE - Germania 393
SE - Svezia 339
IE - Irlanda 300
FR - Francia 290
FI - Finlandia 229
BD - Bangladesh 222
KR - Corea 152
CA - Canada 123
IN - India 86
NL - Olanda 77
AR - Argentina 62
UA - Ucraina 56
TR - Turchia 52
ES - Italia 51
MX - Messico 51
JP - Giappone 49
AT - Austria 44
BE - Belgio 43
ID - Indonesia 43
IQ - Iraq 40
PL - Polonia 33
EC - Ecuador 30
ZA - Sudafrica 30
NG - Nigeria 28
UZ - Uzbekistan 24
CO - Colombia 21
TG - Togo 20
VE - Venezuela 20
MA - Marocco 19
PK - Pakistan 18
BJ - Benin 16
CL - Cile 16
IR - Iran 16
AU - Australia 13
SA - Arabia Saudita 13
JO - Giordania 11
PH - Filippine 11
KE - Kenya 10
LT - Lituania 10
NO - Norvegia 10
TN - Tunisia 10
EG - Egitto 9
KG - Kirghizistan 9
PY - Paraguay 9
JM - Giamaica 8
CH - Svizzera 7
CR - Costa Rica 7
IL - Israele 7
LV - Lettonia 7
PE - Perù 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
AL - Albania 5
MY - Malesia 5
OM - Oman 5
GA - Gabon 4
NI - Nicaragua 4
PT - Portogallo 4
RO - Romania 4
RS - Serbia 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
IS - Islanda 2
KW - Kuwait 2
LB - Libano 2
Totale 19.840
Città #
Southend 1.322
Singapore 936
Moscow 881
Ashburn 759
Dallas 687
Chandler 654
San Jose 642
Verona 434
Hong Kong 426
Woodbridge 316
Beijing 292
Council Bluffs 292
Dublin 280
Ann Arbor 259
Jacksonville 242
New York 220
The Dalles 199
Ho Chi Minh City 131
Munich 126
Los Angeles 123
Jinan 100
Hanoi 97
Shenyang 97
Lawrence 86
Princeton 86
Houston 85
Nanjing 75
Wilmington 75
Helsinki 67
São Paulo 65
Santa Clara 64
Hebei 57
Tianjin 53
Turku 53
Buffalo 50
London 50
Redondo Beach 50
Milan 46
Zhengzhou 46
Orem 45
Columbus 42
Redmond 42
Brussels 41
Changsha 41
Haikou 41
Montreal 40
Ningbo 38
Hangzhou 36
Nanchang 34
Taizhou 34
Tokyo 34
Guangzhou 33
Sindelfingen 33
Seattle 32
Seoul 31
Vienna 31
Frankfurt am Main 30
Rome 30
Shanghai 30
Toronto 30
Dong Ket 28
Lancaster 28
Abuja 27
Brescia 26
Jiaxing 26
Johannesburg 26
Amsterdam 25
Warsaw 25
Brooklyn 23
Da Nang 23
Haiphong 23
Jakarta 23
Chennai 22
Madrid 22
Mexico City 22
Nuremberg 22
San Francisco 22
Taiyuan 21
Bologna 20
Lanzhou 20
Lomé 20
Tashkent 20
Dearborn 19
Chicago 18
Kent 18
Lappeenranta 18
Manchester 18
Stockholm 18
Baghdad 17
Belo Horizonte 17
Boardman 17
Poplar 17
Cotonou 16
Denver 16
Rio de Janeiro 16
Norwalk 15
Paris 15
Phoenix 15
Redwood City 15
Atlanta 14
Totale 12.084
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 385
Whole-genome landscape of pancreatic neuroendocrine tumours 286
Characterization of new monoclonal antibodies specific for the extracellular domain of PTPRG, a candidate tumour suppressor gene 285
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 284
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 272
Genomic characterization of hepatoid tumors: context matters 261
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 257
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 255
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 254
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 249
Nuovi approcci proteomici per l'identificazione di potenziali marcatori di neoplasie pancreatiche 248
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 244
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 240
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel 237
Expression of transmembrane protein tyrosine phosphatase gamma (Ptpgamma) in normal and neoplastic human tissues. 232
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 229
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 229
MONOCLONAL ANTIBODY FOR DIAGNOSING CHRONIC MYELOID LEUKEMIA 220
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 220
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 218
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 216
Immunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues 215
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 214
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 212
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 211
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 206
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
Urokinase Plasminogen Activator Receptor Could Be a New UsefulMarker in Pancreatic Cancer and Appears to Be Related to Survival 205
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 201
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 200
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 199
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 198
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers 196
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 195
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 195
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 194
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 193
PTPRG Expression Correlates with Tolerogenic Phenotype in Dendritic Cells Derived from Pancreatic Cancer Patients 192
Pancreatic cancer genomics 192
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 192
Comparative Lesions Analysis Through a Targeted Sequencing Approach 190
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 189
Author Correction: The landscape of viral associations in human cancers 189
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 187
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 187
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 186
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 184
Fhit down-regulation is an early event in pancreatic carcinogenesis 179
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 179
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 178
Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts. 176
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes 175
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 175
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 175
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 172
Splice variants as novel targets in pancreatic ductal adenocarcinoma 172
FrequentNRG1fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression 170
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer 169
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium 168
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 168
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 165
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 165
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 165
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages 160
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 159
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 158
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 157
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 153
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 152
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 152
ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. 150
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 149
Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin 148
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 147
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 147
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 147
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 144
Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients 143
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 139
Genomic landscape of pancreatic neuroendocrine tumours: The International Cancer Genome Consortium 139
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling 134
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 131
Receptor type tyrosine phosphatase gamma (PTP gamma) is a novel dendritic cell marker 131
Comprehensive molecular characterization of mitochondrial genomes in human cancers 130
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 129
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 128
Recurrent oligodendroglioma with changed 1p/19q status 123
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 123
Solitary subependymal giant cell astrocytoma lacking TSC1/2 mutations and TTF-1 expression: A potential diagnostic pitfall 121
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 120
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities 119
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 118
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis 118
The landscape of viral associations in human cancers 116
Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy 113
Cerebellar mass in a 31-year-old woman 112
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 111
Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type Lesions 110
New genomic landscapes and therapeutic targets for biliary tract cancers 109
Totale 18.232
Categoria #
all - tutte 67.134
article - articoli 58.138
book - libri 0
conference - conferenze 7.253
curatela - curatele 0
other - altro 509
patent - brevetti 557
selected - selezionate 0
volume - volumi 677
Totale 134.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 324 54 74 59 24 33 66 31 29 74 193
2022/20231.779 113 230 142 293 156 441 14 123 199 11 30 27
2023/20241.107 48 69 72 99 116 219 46 119 16 73 183 47
2024/20253.064 127 141 172 466 183 142 198 150 397 183 341 564
2025/20269.085 569 479 704 1.409 2.195 571 753 503 753 580 244 325
2026/2027341 137 204 0 0 0 0 0 0 0 0 0 0
Totale 20.127